Portfolio Overview

 

The Medical Technology Stock Letter currently covers the companies listed below.  The majority of our portfolio have been long-term investments; MTSL consistently adds new independent recommendations (e.g., MDGL and ESPR were new ideas in 2016 and 2017, respectively). Click on the company name for general information about the company, our CEO insight, a link to the company pipeline and government registry and results database on completed, ongoing and planned clinical trials.

Portfolio company updates are our analysis of key recent and upcoming near-term events and catalysts specific to each company, accompanied by our BUY LIMIT and TARGET PRICE. In-depth coverage and complete updates of the companies in our portfolio are available only to MTSL subscribers.*

Subscribe to the Medical Technology Stock Letter

Ticker

Company

Updates

ACAD Acadia Get latest update
ALKS Alkermes Get latest update
ANTH Anthera Get latest update
BMRN BioMarin Get latest update
CBMG Cellular Biomed Get latest update
CELG Celgene Get latest update
ESPR Esperion Get latest update
FPRX Five Prime Get latest update
IMGN ImmunoGen Get latest update
INCY Incyte Get latest update
IONS Ionis Get latest update
MDGL Madrigal Get latest update
MDCO The Medicines Company Get latest update
MYOV Myovant Get latest update
NKTR Nektar Therap. Get latest update
NVAX Novavax Get latest update
PCRX Pacira Get latest update
SGMO Sangamo Get latest update
ZIOP Ziopharm Get latest update

*Disclaimer